MapLight Therapeutics, Inc. (MPLT)
NASDAQ: MPLT · Real-Time Price · USD
13.77
+0.63 (4.79%)
Sep 4, 2026, 4:00 PM EDT - Market closed
MapLight Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 71.63 | 46.73 | 38.25 | 79.77 | 27.67 |
Short-Term Investments | 233.09 | 258.37 | 70.54 | - | - |
Cash & Short-Term Investments | 304.73 | 305.1 | 108.8 | 79.77 | 27.67 |
Cash Growth | 403.91% | 180.44% | 36.39% | 188.34% | - |
Prepaid Expenses | 14.06 | 19.57 | 5.81 | 3.84 | 4.37 |
Total Current Assets | 318.79 | 324.67 | 114.6 | 83.6 | 32.03 |
Property, Plant & Equipment | 2.5 | 6.58 | 7.56 | 6.59 | 7.12 |
Long-Term Investments | 46.62 | 147.99 | 11.38 | 0.99 | - |
Long-Term Deferred Charges | - | - | 3 | - | - |
Other Long-Term Assets | 0.45 | 0.27 | 0.37 | 0.23 | 0.23 |
Total Assets | 368.35 | 479.51 | 136.92 | 91.41 | 39.39 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Accounts Payable | 2.05 | 3.29 | 1.91 | 3.25 | 3.6 |
Accrued Expenses | 16.01 | 12.05 | 9.99 | 6.76 | 2.79 |
Current Portion of Leases | 1.23 | 0.89 | 0.78 | 0.5 | 0.35 |
Current Unearned Revenue | - | - | 3.24 | 4.2 | 5.86 |
Total Current Liabilities | 19.29 | 16.23 | 15.92 | 14.7 | 12.6 |
Long-Term Leases | 0.76 | 4.91 | 5.8 | 5.43 | 5.92 |
Total Liabilities | 20.05 | 21.14 | 21.72 | 20.13 | 18.52 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Common Stock | 0.01 | 0.01 | - | - | - |
Additional Paid-In Capital | 830.62 | 819.12 | 5.58 | 4.2 | 3.12 |
Retained Earnings | -481.38 | -360.52 | -199.37 | -121.79 | -66.08 |
Comprehensive Income & Other | -0.94 | -0.23 | 0.16 | - | - |
Total Common Equity | 348.3 | 458.37 | -193.63 | -117.59 | -62.96 |
Shareholders' Equity | 348.3 | 458.37 | 115.2 | 71.28 | 20.87 |
Total Liabilities & Equity | 368.35 | 479.51 | 136.92 | 91.41 | 39.39 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Total Debt | 1.99 | 5.8 | 6.58 | 5.92 | 6.27 |
Net Cash (Debt) | 302.74 | 299.3 | 102.22 | 73.85 | 21.39 |
Net Cash Growth | 457.87% | 192.81% | 38.42% | 245.17% | - |
Net Cash Per Share | 9.77 | 34.48 | 138.85 | 111.94 | 38.41 |
Filing Date Shares Outstanding | 46.38 | 44.02 | 0.76 | 0.67 | 0.56 |
Total Common Shares Outstanding | 45.44 | 44.02 | 0.76 | 0.67 | 0.56 |
Working Capital | 299.49 | 308.44 | 98.68 | 68.91 | 19.44 |
Book Value Per Share | 7.67 | 10.41 | -254.32 | -176.19 | -113.03 |
Tangible Book Value | 348.3 | 458.37 | -193.63 | -117.59 | -62.96 |
Tangible Book Value Per Share | 7.67 | 10.41 | -254.32 | -176.19 | -113.03 |
Machinery | - | 3.69 | 3.25 | 2.77 | 2.22 |
Leasehold Improvements | - | - | - | 0.01 | - |